Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Insulin Resistance
Interventions
DRUG:
Intranasal insulin
DRUG:
Intranasal placebo
Sponsor
University Health Network, Toronto